• 1
    Hazlewood GS, Naimark D, Gardam M, Bykerk V, Bombardier C.Prophylaxis for latent tuberculosis infection prior to anti–tumor necrosis factor therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis.Arthritis Care Res (Hoboken)2013;65:172231.
  • 2
    Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.MMWR Recomm Rep2000;49:151.
  • 3
    Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, et al.Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).Ann Rheum Dis2010;69:5228.
  • 4
    Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Breban M, et al.Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry.Arthritis Rheum2009;60:188494.
  • 5
    Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW, et al.Mycobacterial diseases and anti–tumour necrosis factor therapy in USA.Ann Rheum Dis2013;72:3742.
  • 6
    Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, Montero D, Pascual-Gomez E, Mola EM, et al, for the BIOBADASER Group.Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.Arthritis Rheum2005;52:176672.
  • 7
    Nolan CM, Goldberg SV, Buskin SE.Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.JAMA1999;281:10148.
  • 8
    Ziakas PD, Mylonakis E.Four months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity.Clin Infect Dis2009;49:18839.
  • 9
    Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, et al.Three months of rifapentine and isoniazid for latent tuberculosis infection.N Engl J Med2011;365:215566.